Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Oliver Lagore Vanvalin Investment Group

Oliver Lagore Vanvalin Investment Group increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,431 shares of the medical equipment provider’s stock after purchasing an additional 446 shares during the period. Oliver Lagore Vanvalin Investment Group’s holdings in Intuitive Surgical were worth $1,971,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in ISRG. Vanguard Group Inc. grew its holdings in Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after acquiring an additional 493,126 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock valued at $5,726,102,000 after purchasing an additional 272,741 shares in the last quarter. Capital World Investors grew its stake in shares of Intuitive Surgical by 1.0% in the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after purchasing an additional 73,634 shares during the last quarter. Edgewood Management LLC raised its holdings in shares of Intuitive Surgical by 7.9% in the 4th quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock worth $1,731,016,000 after purchasing an additional 374,667 shares in the last quarter. Finally, Jennison Associates LLC lifted its stake in Intuitive Surgical by 4.6% during the first quarter. Jennison Associates LLC now owns 4,488,343 shares of the medical equipment provider’s stock valued at $1,791,253,000 after purchasing an additional 198,483 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research reports. BTIG Research raised their price objective on Intuitive Surgical from $469.00 to $494.00 and gave the stock a “buy” rating in a research note on Wednesday, August 28th. Citigroup lifted their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a report on Friday, July 19th. Evercore ISI reduced their price target on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research report on Friday, July 19th. Finally, Robert W. Baird boosted their target price on shares of Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research note on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $446.45.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 2,818 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $1,291,010.34. Following the completion of the transaction, the executive vice president now owns 298 shares of the company’s stock, valued at approximately $136,522.74. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Intuitive Surgical news, EVP Myriam Curet sold 2,818 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $1,291,010.34. Following the sale, the executive vice president now owns 298 shares of the company’s stock, valued at approximately $136,522.74. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 1,413 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $438.60, for a total value of $619,741.80. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,414,931.60. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock worth $25,528,753 over the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 1.5 %

Shares of NASDAQ:ISRG opened at $479.18 on Friday. The stock has a market capitalization of $169.97 billion, a PE ratio of 86.49, a P/E/G ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $496.18. The firm has a fifty day moving average price of $473.03 and a 200 day moving average price of $428.22.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the prior year, the company posted $1.18 EPS. The firm’s revenue was up 14.5% on a year-over-year basis. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.